Corient Private Wealth’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.61M | Sell |
72,402
-4,510
| -6% | -$162K | ﹤0.01% | 1001 |
|
|
2025
Q1 | $2.39M | Buy |
76,912
+30,663
| +66% | +$955K | ﹤0.01% | 910 |
|
|
2024
Q4 | $1.18M | Buy |
46,249
+21,383
| +86% | +$545K | ﹤0.01% | 1243 |
|
|
2024
Q3 | $703K | Sell |
24,866
-1,982
| -7% | -$56.1K | ﹤0.01% | 1544 |
|
|
2024
Q2 | $708K | Buy |
26,848
+214
| +0.8% | +$5.64K | ﹤0.01% | 1462 |
|
|
2024
Q1 | $809K | Buy |
26,634
+5,288
| +25% | +$161K | ﹤0.01% | 1384 |
|
|
2023
Q4 | $600K | Buy |
+21,346
| New | +$600K | ﹤0.01% | 1519 |
|
|
2023
Q2 | – | Sell |
-6,275
| Closed | -$226K | – | 2128 |
|
|
2023
Q1 | $226K | Buy |
+6,275
| New | +$226K | ﹤0.01% | 1733 |
|